Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2013 / Cilt: 59 - Sayı: 1

Romatoid artritte serum melatonin düzeyleri

Melatonin serum levels in rheumatoid arthritis

Pages
42–44
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The Mann-Whitney U-test was used to compare the data between the two groups.Results: MLT concentrations were significantly higher in RA patients thanin the controls (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Recent studies suggest that endogenous melatonin (MLT)production might play a role in the etiology of rheumatoid arthritis (RA).However, the role of MLT in RA pathogenesis remains unclear.
📊
Key Findings & Data:This studywas performed to determine MLT serum levels in RA patients.Materials and Methods: Twenty nine patients with RA and in 25 age- andsex-matched healthy controls were included in our study.
💡
Conclusion & Impact:The Mann-Whitney U-test was used to compare the data between the two groups.Results: MLT concentrations were significantly higher in RA patients thanin the controls (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Recent studies suggest that endogenous melatonin (MLT)production might play a role in the etiology of rheumatoid arthritis (RA).However, the role of MLT in RA pathogenesis remains unclear. This studywas performed to determine MLT serum levels in RA patients.Materials and Methods: Twenty nine patients with RA and in 25 age- andsex-matched healthy controls were included in our study. Blood samplesof the participants collected at 8AM. MLT was measured by enzyme-linkedimmunosorbent assay (ELISA). The MLT levels of the patients with RAwere compared with healthy age- and sex-matched controls. The Mann-Whitney U-test was used to compare the data between the two groups.Results: MLT concentrations were significantly higher in RA patients thanin the controls (p

Özet

Amaç: Son çalışmalar endojen melatonin (MLT) üretiminin romatoid artrit (RA) etyolojisinde rol oynayabileceğini ileri sürmektedir. Ancak MLT’nin RA patogenezindeki rolü açık değildir. Bu çalışma RA’lı hastalarda MLT düzeylerini belirlemek için düzenlenmiştir. Gereç ve Yöntem: Çalışmamıza 29 RA hastası ile yaş ve cins olarak eşleştirilmiş 25 sağlıklı kontrol dahil edildi Katılımcıların kan örnekleri sabah 8:00’da alındı. MLT enzyme-linked immunosorbent assay (ELISA) yöntemiyle ölçüldü. RA hastalarının MLT düzeyleri yaş ve cins olarak eşleştirilmiş kontroller ile karşılaştırıldı. Gruplar arasındaki verilerin karşılaştırılmasında Mann-Whitney U test kullanıldı. Bulgular: MLT düzeyleri RA hastalarında kontrol grubundan anlamlı olarak daha yüksekti (p

🔖

Cite This Article

ERDAL, A., UĞUR, M., ŞENEL, K., ALKAN, M. M., BAYKAL, T., ALP, H. H. (2022). Romatoid artritte serum melatonin düzeyleri. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 59 - Sayı: 1, 42–44. https://ajindex.com/articles/628853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ha C, Choe BK, Jung KH, Yoon SH, Park HJ, Park HK, et al. Positive relationship between melatonin receptor type 1B polymorfism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 2005;39:201-5
  2. Maestroni GJ, Cardinali DP Esquitino Al, Pandi-Perumal SR. Does, melatonin play a disease-promoting role in rheumatoid arthritis? Neuroimmunol 2005;158:106-11
  3. Forrest CM, Mackay GM, Stay N, Stone TW, Darlington LG. Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 2007;64:517-26
  4. Akyol O, Isci N, Temel I, Ozgocmen S, Uz E, Murat M, Buyukberber S. The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 2001;68:311-7.44 5. Kamanlı A, Naziroğlu M, Aydilek N, Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Function 2003;22:53-7
  5. Korkmaz A. Melatonin as an adjuvant therapy in patients with rheumatoid arthritis. Br J Clin Pharmacol 2008;66:316-7
  6. Reiter RJ. Melatonin; Clinical relevance. Best Pract Res Clin Endocrinol Mel 2003;17:273-85
  7. Maestroni GJ, Otsa K, Cutolo M. Melatonin treatment does not improve rheumatoid arthritis. Br J Clin Pharmacol 2007;65:797-8
  8. West SK, Oosthuizen JM. Melatonin levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 1992;3:33-40
  9. Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S, et al. Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a North and South Europa comparison. Ann Rheum Dis 2005;64:212-6
  10. Altun A, Uygur-Altun B. Melatonin therapeutic and clinical utilization. Int J Clin Pract 2007;61:835-45
  11. Reiter RJ, Tan DX, Manchester LC, Pilar Terron M, Flores LJ, Koppisepi S. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007;52:11-28
  12. Kalpakcioglu B, Senel K. The role of melatonin in rheumatic diseases. Infect Disord Drug Targets 2009;9:453-6
  13. Cutolo M, Seriolo B, Craviotto C, Pizzomi C, Sulli A. Circadian rhythms in RA. Ann Rheum Dis 2003;62:593-6
  14. Cutolo M, Villaggio B, Otsa K, Aakre O, Sulli A, Seriolo B. Altered circadian rhythyms in rheumatoid arthritis patients play a role in the disease’s symptoms. Autoimmune Rev 2005;4:497-502
  15. Cutolo M, Maestroni GJ. The melatonin-cytokine connection in